Company / PP&E (Net)
AIM ImmunoTech Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$71.0K
FY2025
5-year range
$71.0K / $4.0M
FY2021-FY2025
Trend
-34.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has declined for 9 consecutive years, from $10M in FY2016 to $71,000 in FY2025.
Based on SEC 10-K filings.
$71,000 in FY2025 with a 5-year CAGR of -59.4%.
Declined from $127,000 to $71,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -28.6%
- 5-Year CAGR
- -59.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- AIM ImmunoTech Inc.'s pp&e (net) has declined for 9 consecutive years.
- 5-year CAGR of -59.4%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 34.3% year-over-year.
- Peak pp&e (net) was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $71.0K | -34.3% |
| FY2024 | $108.0K | -15.0% |
| FY2023 | $127.0K | -34.9% |
| FY2022 | $195.0K | -95.2% |
| FY2021 | $4.0M | -37.5% |
| FY2020 | $6.5M | -9.0% |
| FY2019 | $7.1M | -8.6% |
| FY2018 | $7.8M | -9.4% |
| FY2017 | $8.6M | -9.8% |
| FY2016 | $9.5M | -15.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026